Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle exocytosis (GO:0016079) | 5.06661417 |
2 | cellular potassium ion homeostasis (GO:0030007) | 4.73911342 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.67121787 |
4 | neuronal action potential propagation (GO:0019227) | 4.58582658 |
5 | vocalization behavior (GO:0071625) | 4.44545641 |
6 | neuron cell-cell adhesion (GO:0007158) | 4.38285369 |
7 | glutamate secretion (GO:0014047) | 4.29828176 |
8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.24759616 |
9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.24480503 |
10 | * ATP hydrolysis coupled proton transport (GO:0015991) | 4.21664555 |
11 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.21664555 |
12 | sodium ion export (GO:0071436) | 4.18726917 |
13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.13222206 |
14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.08670337 |
15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.99191173 |
16 | protein localization to synapse (GO:0035418) | 3.96743728 |
17 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.93039465 |
18 | ATP synthesis coupled proton transport (GO:0015986) | 3.93039465 |
19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.85514898 |
20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.84473981 |
21 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.84371876 |
22 | * transferrin transport (GO:0033572) | 3.82624183 |
23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.81198374 |
24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.79947529 |
25 | regulation of synaptic vesicle transport (GO:1902803) | 3.75253502 |
26 | neurotransmitter secretion (GO:0007269) | 3.74122390 |
27 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.73638433 |
28 | regulation of oxidative phosphorylation (GO:0002082) | 3.72803061 |
29 | neuron-neuron synaptic transmission (GO:0007270) | 3.68972633 |
30 | * trivalent inorganic cation transport (GO:0072512) | 3.54223623 |
31 | * ferric iron transport (GO:0015682) | 3.54223623 |
32 | glutamate receptor signaling pathway (GO:0007215) | 3.54089200 |
33 | respiratory electron transport chain (GO:0022904) | 3.54047523 |
34 | regulation of glutamate secretion (GO:0014048) | 3.48257139 |
35 | electron transport chain (GO:0022900) | 3.47229317 |
36 | behavioral response to cocaine (GO:0048148) | 3.43821686 |
37 | synaptic vesicle maturation (GO:0016188) | 3.40689263 |
38 | synaptic transmission, glutamatergic (GO:0035249) | 3.40330631 |
39 | presynaptic membrane assembly (GO:0097105) | 3.39169188 |
40 | regulation of early endosome to late endosome transport (GO:2000641) | 3.36364035 |
41 | detection of calcium ion (GO:0005513) | 3.35069479 |
42 | * phagosome maturation (GO:0090382) | 3.29727183 |
43 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.29570092 |
44 | neurotransmitter transport (GO:0006836) | 3.28901656 |
45 | potassium ion homeostasis (GO:0055075) | 3.26613823 |
46 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.25858192 |
47 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25239999 |
48 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.25209442 |
49 | presynaptic membrane organization (GO:0097090) | 3.24809678 |
50 | chaperone-mediated protein transport (GO:0072321) | 3.23540193 |
51 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.23331945 |
52 | long-term synaptic potentiation (GO:0060291) | 3.22982350 |
53 | locomotory exploration behavior (GO:0035641) | 3.22804698 |
54 | neuron recognition (GO:0008038) | 3.21669066 |
55 | regulation of vesicle fusion (GO:0031338) | 3.19089046 |
56 | protein maturation by protein folding (GO:0022417) | 3.15011766 |
57 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.14191651 |
58 | regulation of postsynaptic membrane potential (GO:0060078) | 3.11464308 |
59 | synaptic transmission, dopaminergic (GO:0001963) | 3.10637223 |
60 | vesicle docking involved in exocytosis (GO:0006904) | 3.10108356 |
61 | negative regulation of amino acid transport (GO:0051956) | 3.09156082 |
62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.08685292 |
63 | response to histamine (GO:0034776) | 3.08361999 |
64 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.04865548 |
65 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04011339 |
66 | gamma-aminobutyric acid transport (GO:0015812) | 3.03409292 |
67 | Golgi transport vesicle coating (GO:0048200) | 3.03247095 |
68 | COPI coating of Golgi vesicle (GO:0048205) | 3.03247095 |
69 | exploration behavior (GO:0035640) | 3.02007056 |
70 | synaptic vesicle endocytosis (GO:0048488) | 3.01537003 |
71 | regulation of neurotransmitter secretion (GO:0046928) | 3.00964415 |
72 | regulation of neurotransmitter levels (GO:0001505) | 3.00051417 |
73 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.98296122 |
74 | positive regulation of membrane potential (GO:0045838) | 2.94788271 |
75 | proline transport (GO:0015824) | 2.94725619 |
76 | amino acid import (GO:0043090) | 2.94347483 |
77 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.93815238 |
78 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93097956 |
79 | protein localization to endosome (GO:0036010) | 2.92940931 |
80 | regulation of dopamine metabolic process (GO:0042053) | 2.92629705 |
81 | regulation of catecholamine metabolic process (GO:0042069) | 2.92629705 |
82 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.91874568 |
83 | L-amino acid import (GO:0043092) | 2.91417674 |
84 | glycosphingolipid catabolic process (GO:0046479) | 2.90473123 |
85 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90100233 |
86 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.89621328 |
87 | * hydrogen ion transmembrane transport (GO:1902600) | 2.88693138 |
88 | transmission of nerve impulse (GO:0019226) | 2.88655665 |
89 | regulation of synaptic plasticity (GO:0048167) | 2.88229293 |
90 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.86822045 |
91 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.86600086 |
92 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.86600086 |
93 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.86102305 |
94 | negative regulation of neurotransmitter transport (GO:0051589) | 2.85225266 |
95 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.84485861 |
96 | establishment of synaptic vesicle localization (GO:0097480) | 2.82375014 |
97 | synaptic vesicle transport (GO:0048489) | 2.82375014 |
98 | regulation of protein kinase A signaling (GO:0010738) | 2.82206478 |
99 | regulation of neurotransmitter transport (GO:0051588) | 2.81772552 |
100 | long-term memory (GO:0007616) | 2.81287543 |
101 | regulation of synapse structural plasticity (GO:0051823) | 2.81144397 |
102 | vesicle docking (GO:0048278) | 2.80898022 |
103 | fear response (GO:0042596) | 2.79607165 |
104 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.79210840 |
105 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.79000515 |
106 | neuromuscular process controlling posture (GO:0050884) | 2.78604298 |
107 | negative regulation of amine transport (GO:0051953) | 2.76868165 |
108 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.76751211 |
109 | cerebellar Purkinje cell layer development (GO:0021680) | 2.76323346 |
110 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.76204931 |
111 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.76151494 |
112 | mating behavior (GO:0007617) | 2.73231337 |
113 | postsynaptic membrane organization (GO:0001941) | 2.72775209 |
114 | synaptic transmission (GO:0007268) | 2.72375914 |
115 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.71882349 |
116 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.71334688 |
117 | membrane depolarization (GO:0051899) | 2.70718120 |
118 | protein neddylation (GO:0045116) | 2.70079061 |
119 | behavioral fear response (GO:0001662) | 2.67894916 |
120 | behavioral defense response (GO:0002209) | 2.67894916 |
121 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.67275720 |
122 | response to cocaine (GO:0042220) | 2.67182427 |
123 | positive regulation of protein dephosphorylation (GO:0035307) | 2.65451303 |
124 | potassium ion import (GO:0010107) | 2.65101806 |
125 | dopamine biosynthetic process (GO:0042416) | 2.64737080 |
126 | striatum development (GO:0021756) | 2.64539416 |
127 | startle response (GO:0001964) | 2.63273145 |
128 | adenosine receptor signaling pathway (GO:0001973) | 2.63094271 |
129 | positive regulation of synapse assembly (GO:0051965) | 2.62440142 |
130 | oligosaccharide catabolic process (GO:0009313) | 2.60588131 |
131 | glycolipid catabolic process (GO:0019377) | 2.58376791 |
132 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.55407274 |
133 | cerebellar granule cell differentiation (GO:0021707) | 2.54348841 |
134 | cell communication by electrical coupling (GO:0010644) | 2.54311260 |
135 | response to thyroid hormone (GO:0097066) | 2.53967523 |
136 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.52274289 |
137 | cellular copper ion homeostasis (GO:0006878) | 2.50381076 |
138 | regulation of protein dephosphorylation (GO:0035304) | 2.49604838 |
139 | NADH metabolic process (GO:0006734) | 2.44600101 |
140 | negative regulation of cation channel activity (GO:2001258) | 2.43162699 |
141 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.42705049 |
142 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.40370374 |
143 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.40350845 |
144 | * iron ion transport (GO:0006826) | 2.39970146 |
145 | membrane docking (GO:0022406) | 2.39942398 |
146 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.39663333 |
147 | neuromuscular process controlling balance (GO:0050885) | 2.38629775 |
148 | regulation of ARF protein signal transduction (GO:0032012) | 2.38200001 |
149 | barbed-end actin filament capping (GO:0051016) | 2.36819314 |
150 | clathrin coat assembly (GO:0048268) | 2.35243748 |
151 | regulation of cell communication by electrical coupling (GO:0010649) | 2.35082839 |
152 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.34628567 |
153 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.34049820 |
154 | neurotransmitter uptake (GO:0001504) | 2.33859057 |
155 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.33142387 |
156 | positive regulation of receptor recycling (GO:0001921) | 2.32975080 |
157 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.29981818 |
158 | substantia nigra development (GO:0021762) | 2.29888711 |
159 | positive regulation of synapse maturation (GO:0090129) | 2.28958753 |
160 | regulation of exocytosis (GO:0017157) | 2.27459155 |
161 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.26305525 |
162 | response to acidic pH (GO:0010447) | 2.24396473 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.41780596 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.06988230 |
3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.25154568 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09819604 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92187617 |
6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.80647595 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.80179087 |
8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62599222 |
9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.59846638 |
10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.59322377 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.51260249 |
12 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.50973568 |
13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44863563 |
14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42872902 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40056240 |
16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38552623 |
17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35153230 |
18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.33749938 |
19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.33749938 |
20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.32552267 |
21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26028518 |
22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25964889 |
23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.20752688 |
24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.19888678 |
25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17814360 |
26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.17538733 |
27 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.16580248 |
28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14300523 |
29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13375683 |
30 | VDR_22108803_ChIP-Seq_LS180_Human | 2.10070062 |
31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.06814946 |
32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.02877525 |
33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.99120678 |
34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.98879864 |
35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96581694 |
36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94056662 |
37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.91768745 |
38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88303007 |
39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.87031481 |
40 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.80347278 |
41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77488134 |
42 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.76045536 |
43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75918304 |
44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74413473 |
45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74310623 |
46 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.73954236 |
47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73357435 |
48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.70934868 |
49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70200154 |
50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68275981 |
51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68218294 |
52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.65355951 |
53 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.65284554 |
54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.65032796 |
55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.59740914 |
56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59101141 |
57 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.58245435 |
58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56043329 |
59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55825168 |
60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55660245 |
61 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.55278603 |
62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53897923 |
63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.53532094 |
64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50647475 |
65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47036176 |
66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46290179 |
67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45114669 |
68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44651484 |
69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43526113 |
70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43482165 |
71 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.42041921 |
72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41051126 |
73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.40676207 |
74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39575800 |
75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39535254 |
76 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.38709241 |
77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38666021 |
78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38147382 |
79 | KDM2B_26808549_Chip-Seq_K562_Human | 1.37734952 |
80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34981951 |
81 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34784743 |
82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34530811 |
83 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33950101 |
84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33570016 |
85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33372308 |
86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33318396 |
87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31697514 |
88 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31422286 |
89 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.31260378 |
90 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30929994 |
91 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.30204550 |
92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30139599 |
93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28001546 |
94 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26929591 |
95 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25403901 |
96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24483342 |
97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23193869 |
98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22806008 |
99 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22159465 |
100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20550936 |
101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18872253 |
102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17645830 |
103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17049827 |
104 | * JUN_21703547_ChIP-Seq_K562_Human | 1.16307189 |
105 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16279754 |
106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15632791 |
107 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14782861 |
108 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.14589905 |
109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14451234 |
110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10923747 |
111 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.10560275 |
112 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10531237 |
113 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10342984 |
114 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10079953 |
115 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.07936177 |
116 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07039361 |
117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06073984 |
118 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05918260 |
119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05830184 |
120 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.05739224 |
121 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05614286 |
122 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05578936 |
123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05337064 |
124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05249272 |
125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04915953 |
126 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.03610810 |
127 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03487422 |
128 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03012219 |
129 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02681842 |
130 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02190930 |
131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01478133 |
132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01478133 |
133 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01401278 |
134 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99966503 |
135 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.98461659 |
136 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98379780 |
137 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98146599 |
138 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97997119 |
139 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97895335 |
140 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97551692 |
141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97415811 |
142 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97194831 |
143 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97103472 |
144 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96576766 |
145 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96475719 |
146 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96454300 |
147 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95857334 |
148 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95857334 |
149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95605059 |
150 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95541385 |
151 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95506437 |
152 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95412512 |
153 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93897631 |
154 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.93877285 |
155 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93735079 |
156 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92982897 |
157 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92824947 |
158 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92781581 |
159 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92734087 |
160 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.92241831 |
161 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91495933 |
162 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91383800 |
163 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.91281992 |
164 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90932138 |
165 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90791830 |
166 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90603415 |
167 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89623532 |
168 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89577138 |
169 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88933494 |
170 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.88222763 |
171 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88149086 |
172 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87434955 |
173 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87145315 |
174 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87145315 |
175 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.87095927 |
176 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86811085 |
177 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.86508801 |
178 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86271230 |
179 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.86215706 |
180 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86074419 |
181 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.85956744 |
182 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.84764326 |
183 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84075468 |
184 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83298165 |
185 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82479381 |
186 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.80546092 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 5.22256843 |
2 | MP0004859_abnormal_synaptic_plasticity | 4.85955533 |
3 | MP0005058_abnormal_lysosome_morphology | 3.72464275 |
4 | MP0003635_abnormal_synaptic_transmissio | 3.57103190 |
5 | MP0004270_analgesia | 3.28734972 |
6 | MP0009745_abnormal_behavioral_response | 3.28012586 |
7 | MP0002064_seizures | 3.20340491 |
8 | MP0001968_abnormal_touch/_nociception | 3.19383356 |
9 | MP0009046_muscle_twitch | 3.11948408 |
10 | MP0002063_abnormal_learning/memory/cond | 2.92694178 |
11 | MP0002736_abnormal_nociception_after | 2.92570042 |
12 | MP0002735_abnormal_chemical_nociception | 2.74712013 |
13 | MP0002822_catalepsy | 2.72646499 |
14 | MP0001501_abnormal_sleep_pattern | 2.72237176 |
15 | MP0002572_abnormal_emotion/affect_behav | 2.71035663 |
16 | MP0002272_abnormal_nervous_system | 2.63926246 |
17 | MP0002734_abnormal_mechanical_nocicepti | 2.59364015 |
18 | MP0001440_abnormal_grooming_behavior | 2.54178745 |
19 | MP0009840_abnormal_foam_cell | 2.52422960 |
20 | MP0003172_abnormal_lysosome_physiology | 2.47372640 |
21 | MP0006276_abnormal_autonomic_nervous | 2.37684308 |
22 | MP0002837_dystrophic_cardiac_calcinosis | 2.30208581 |
23 | MP0001529_abnormal_vocalization | 2.24629762 |
24 | MP0000343_altered_response_to | 2.21052504 |
25 | MP0002733_abnormal_thermal_nociception | 2.19174690 |
26 | MP0001970_abnormal_pain_threshold | 2.17558187 |
27 | MP0010386_abnormal_urinary_bladder | 2.15448739 |
28 | MP0001486_abnormal_startle_reflex | 2.12887916 |
29 | MP0001905_abnormal_dopamine_level | 2.07544620 |
30 | MP0003329_amyloid_beta_deposits | 2.04423818 |
31 | MP0002067_abnormal_sensory_capabilities | 2.03198689 |
32 | MP0003191_abnormal_cellular_cholesterol | 1.90068487 |
33 | MP0005423_abnormal_somatic_nervous | 1.77885997 |
34 | MP0001984_abnormal_olfaction | 1.76840085 |
35 | MP0003303_peritoneal_inflammation | 1.76212479 |
36 | MP0006082_CNS_inflammation | 1.76041773 |
37 | MP0004924_abnormal_behavior | 1.74932784 |
38 | MP0005386_behavior/neurological_phenoty | 1.74932784 |
39 | MP0003806_abnormal_nucleotide_metabolis | 1.62900958 |
40 | MP0002184_abnormal_innervation | 1.61829724 |
41 | MP0002877_abnormal_melanocyte_morpholog | 1.58365865 |
42 | MP0004142_abnormal_muscle_tone | 1.49672731 |
43 | MP0005464_abnormal_platelet_physiology | 1.49165119 |
44 | MP0002909_abnormal_adrenal_gland | 1.48334857 |
45 | MP0004858_abnormal_nervous_system | 1.47540258 |
46 | MP0002557_abnormal_social/conspecific_i | 1.46411842 |
47 | MP0005166_decreased_susceptibility_to | 1.45009869 |
48 | MP0005646_abnormal_pituitary_gland | 1.44522753 |
49 | MP0000013_abnormal_adipose_tissue | 1.42077838 |
50 | MP0003123_paternal_imprinting | 1.41216537 |
51 | MP0003186_abnormal_redox_activity | 1.41090400 |
52 | MP0005451_abnormal_body_composition | 1.40128361 |
53 | MP0008569_lethality_at_weaning | 1.39523512 |
54 | MP0010234_abnormal_vibrissa_follicle | 1.38330139 |
55 | MP0000778_abnormal_nervous_system | 1.38206000 |
56 | MP0009780_abnormal_chondrocyte_physiolo | 1.36996903 |
57 | MP0003879_abnormal_hair_cell | 1.36932396 |
58 | MP0002876_abnormal_thyroid_physiology | 1.36322665 |
59 | MP0002066_abnormal_motor_capabilities/c | 1.33381682 |
60 | MP0004811_abnormal_neuron_physiology | 1.32604408 |
61 | MP0002638_abnormal_pupillary_reflex | 1.31656615 |
62 | MP0000955_abnormal_spinal_cord | 1.30505805 |
63 | MP0005165_increased_susceptibility_to | 1.27572022 |
64 | MP0002148_abnormal_hypersensitivity_rea | 1.23982566 |
65 | MP0003633_abnormal_nervous_system | 1.21794928 |
66 | MP0005535_abnormal_body_temperature | 1.21677741 |
67 | MP0005167_abnormal_blood-brain_barrier | 1.19493545 |
68 | MP0002882_abnormal_neuron_morphology | 1.19486492 |
69 | MP0004043_abnormal_pH_regulation | 1.19346066 |
70 | MP0001502_abnormal_circadian_rhythm | 1.18187894 |
71 | MP0000604_amyloidosis | 1.17906690 |
72 | MP0001188_hyperpigmentation | 1.16495832 |
73 | MP0004147_increased_porphyrin_level | 1.15834797 |
74 | MP0003566_abnormal_cell_adhesion | 1.14119842 |
75 | MP0001853_heart_inflammation | 1.12815680 |
76 | MP0000747_muscle_weakness | 1.11858002 |
77 | MP0005171_absent_coat_pigmentation | 1.11515602 |
78 | MP0002295_abnormal_pulmonary_circulatio | 1.10562127 |
79 | MP0002229_neurodegeneration | 1.10399737 |
80 | MP0004742_abnormal_vestibular_system | 1.09497064 |
81 | MP0005645_abnormal_hypothalamus_physiol | 1.07986162 |
82 | MP0003631_nervous_system_phenotype | 1.07339237 |
83 | MP0001986_abnormal_taste_sensitivity | 1.05450967 |
84 | MP0008872_abnormal_physiological_respon | 1.04385656 |
85 | MP0003122_maternal_imprinting | 1.03075701 |
86 | MP0000920_abnormal_myelination | 1.01399473 |
87 | MP0005379_endocrine/exocrine_gland_phen | 0.99395179 |
88 | MP0005551_abnormal_eye_electrophysiolog | 0.94905137 |
89 | MP0003634_abnormal_glial_cell | 0.93131516 |
90 | MP0000749_muscle_degeneration | 0.89020494 |
91 | MP0008438_abnormal_cutaneous_collagen | 0.88744873 |
92 | MP0002090_abnormal_vision | 0.88612221 |
93 | MP0003195_calcinosis | 0.88212817 |
94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87917269 |
95 | MP0008874_decreased_physiological_sensi | 0.87485956 |
96 | MP0002069_abnormal_eating/drinking_beha | 0.86571740 |
97 | MP0001963_abnormal_hearing_physiology | 0.86502013 |
98 | MP0004484_altered_response_of | 0.84636104 |
99 | MP0003300_gastrointestinal_ulcer | 0.82865899 |
100 | MP0008260_abnormal_autophagy | 0.82337921 |
101 | MP0001542_abnormal_bone_strength | 0.81712327 |
102 | MP0002163_abnormal_gland_morphology | 0.80990873 |
103 | MP0003656_abnormal_erythrocyte_physiolo | 0.80414511 |
104 | MP0003690_abnormal_glial_cell | 0.79826596 |
105 | MP0004885_abnormal_endolymph | 0.78938503 |
106 | MP0001727_abnormal_embryo_implantation | 0.78668496 |
107 | MP0000751_myopathy | 0.78653298 |
108 | MP0004145_abnormal_muscle_electrophysio | 0.78029646 |
109 | MP0003632_abnormal_nervous_system | 0.76869285 |
110 | MP0003787_abnormal_imprinting | 0.75045704 |
111 | MP0002152_abnormal_brain_morphology | 0.73897448 |
112 | MP0003950_abnormal_plasma_membrane | 0.73566301 |
113 | MP0002972_abnormal_cardiac_muscle | 0.72780270 |
114 | MP0006035_abnormal_mitochondrial_morpho | 0.72719226 |
115 | MP0002139_abnormal_hepatobiliary_system | 0.72461903 |
116 | MP0005623_abnormal_meninges_morphology | 0.71780706 |
117 | MP0004019_abnormal_vitamin_homeostasis | 0.71248940 |
118 | MP0004085_abnormal_heartbeat | 0.70874143 |
119 | MP0001664_abnormal_digestion | 0.70696664 |
120 | MP0001756_abnormal_urination | 0.70421134 |
121 | MP0002998_abnormal_bone_remodeling | 0.70414007 |
122 | MP0002752_abnormal_somatic_nervous | 0.70231329 |
123 | MP0000372_irregular_coat_pigmentation | 0.70085262 |
124 | MP0001533_abnormal_skeleton_physiology | 0.67892362 |
125 | MP0003453_abnormal_keratinocyte_physiol | 0.67178199 |
126 | MP0004233_abnormal_muscle_weight | 0.66611067 |
127 | MP0009785_altered_susceptibility_to | 0.66505284 |
128 | MP0001765_abnormal_ion_homeostasis | 0.66148209 |
129 | MP0003646_muscle_fatigue | 0.66043347 |
130 | MP0002419_abnormal_innate_immunity | 0.65955552 |
131 | MP0001348_abnormal_lacrimal_gland | 0.65812999 |
132 | MP0000538_abnormal_urinary_bladder | 0.65365151 |
133 | MP0005409_darkened_coat_color | 0.64610861 |
134 | MP0002693_abnormal_pancreas_physiology | 0.62892852 |
135 | MP0002332_abnormal_exercise_endurance | 0.62263733 |
136 | MP0003183_abnormal_peptide_metabolism | 0.61507478 |
137 | MP0005000_abnormal_immune_tolerance | 0.61337798 |
138 | MP0004510_myositis | 0.60930862 |
139 | MP0006036_abnormal_mitochondrial_physio | 0.60482500 |
140 | MP0004215_abnormal_myocardial_fiber | 0.59888035 |
141 | MP0004947_skin_inflammation | 0.59751522 |
142 | MP0004036_abnormal_muscle_relaxation | 0.58020838 |
143 | MP0003075_altered_response_to | 0.56345483 |
144 | MP0001485_abnormal_pinna_reflex | 0.55352515 |
145 | MP0005499_abnormal_olfactory_system | 0.55294243 |
146 | MP0005394_taste/olfaction_phenotype | 0.55294243 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.21219825 |
2 | Myokymia (HP:0002411) | 5.16365244 |
3 | Atonic seizures (HP:0010819) | 5.03578328 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.86713095 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.86713095 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.86713095 |
7 | Focal seizures (HP:0007359) | 4.81093388 |
8 | Visual hallucinations (HP:0002367) | 4.72159692 |
9 | Acute necrotizing encephalopathy (HP:0006965) | 4.52067048 |
10 | Epileptic encephalopathy (HP:0200134) | 4.38422971 |
11 | Absence seizures (HP:0002121) | 4.25783462 |
12 | Febrile seizures (HP:0002373) | 4.17587633 |
13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.17082460 |
14 | Dialeptic seizures (HP:0011146) | 4.03019189 |
15 | Progressive macrocephaly (HP:0004481) | 3.94697616 |
16 | Mitochondrial inheritance (HP:0001427) | 3.74770343 |
17 | Hyperventilation (HP:0002883) | 3.69849143 |
18 | Generalized tonic-clonic seizures (HP:0002069) | 3.65072960 |
19 | Acute encephalopathy (HP:0006846) | 3.57426094 |
20 | Pheochromocytoma (HP:0002666) | 3.27770293 |
21 | Supranuclear gaze palsy (HP:0000605) | 3.16467839 |
22 | Amblyopia (HP:0000646) | 3.14462930 |
23 | Dysostosis multiplex (HP:0000943) | 3.13934523 |
24 | Progressive cerebellar ataxia (HP:0002073) | 3.11502193 |
25 | Cerebral inclusion bodies (HP:0100314) | 3.11029199 |
26 | Increased CSF lactate (HP:0002490) | 3.10544099 |
27 | Neuroendocrine neoplasm (HP:0100634) | 3.10106176 |
28 | Apathy (HP:0000741) | 3.02337008 |
29 | Diminished motivation (HP:0000745) | 2.92174275 |
30 | Neuronal loss in central nervous system (HP:0002529) | 2.91805100 |
31 | Vacuolated lymphocytes (HP:0001922) | 2.91642753 |
32 | Neurofibrillary tangles (HP:0002185) | 2.88226124 |
33 | Hepatocellular necrosis (HP:0001404) | 2.87340243 |
34 | Loss of speech (HP:0002371) | 2.81369536 |
35 | Anxiety (HP:0000739) | 2.81026616 |
36 | Tetraplegia (HP:0002445) | 2.79588939 |
37 | Hypothermia (HP:0002045) | 2.76880891 |
38 | Axonal loss (HP:0003447) | 2.68439146 |
39 | Limb dystonia (HP:0002451) | 2.68022532 |
40 | Broad-based gait (HP:0002136) | 2.65862584 |
41 | Abnormal eating behavior (HP:0100738) | 2.64150094 |
42 | Focal dystonia (HP:0004373) | 2.63751605 |
43 | Craniofacial dystonia (HP:0012179) | 2.60604982 |
44 | Progressive inability to walk (HP:0002505) | 2.60407768 |
45 | Nuclear cataract (HP:0100018) | 2.58668072 |
46 | Polyphagia (HP:0002591) | 2.56915602 |
47 | Optic disc pallor (HP:0000543) | 2.55768761 |
48 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.54264946 |
49 | Increased hepatocellular lipid droplets (HP:0006565) | 2.52583401 |
50 | Delusions (HP:0000746) | 2.51665238 |
51 | Progressive neurologic deterioration (HP:0002344) | 2.50356409 |
52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45984033 |
53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45984033 |
54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45984033 |
55 | Mucopolysacchariduria (HP:0008155) | 2.39776384 |
56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39776384 |
57 | Increased serum pyruvate (HP:0003542) | 2.38998866 |
58 | Abnormality of glycolysis (HP:0004366) | 2.38998866 |
59 | Cerebral hypomyelination (HP:0006808) | 2.36886101 |
60 | Action tremor (HP:0002345) | 2.36821361 |
61 | Gait imbalance (HP:0002141) | 2.36648303 |
62 | Rigidity (HP:0002063) | 2.36323348 |
63 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.35740934 |
64 | Torticollis (HP:0000473) | 2.35135411 |
65 | Poor eye contact (HP:0000817) | 2.34726316 |
66 | Truncal ataxia (HP:0002078) | 2.34591188 |
67 | Epileptiform EEG discharges (HP:0011182) | 2.34007206 |
68 | Petechiae (HP:0000967) | 2.33132351 |
69 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.32729625 |
70 | Leukodystrophy (HP:0002415) | 2.32570130 |
71 | Dysmetria (HP:0001310) | 2.31290568 |
72 | Abnormality of binocular vision (HP:0011514) | 2.31168920 |
73 | Diplopia (HP:0000651) | 2.31168920 |
74 | Renal Fanconi syndrome (HP:0001994) | 2.30707562 |
75 | Cerebral edema (HP:0002181) | 2.30070758 |
76 | Vertebral compression fractures (HP:0002953) | 2.29131837 |
77 | Intention tremor (HP:0002080) | 2.28535525 |
78 | Medial flaring of the eyebrow (HP:0010747) | 2.26598149 |
79 | Hypokinesia (HP:0002375) | 2.25394413 |
80 | Gaze-evoked nystagmus (HP:0000640) | 2.24633851 |
81 | Inability to walk (HP:0002540) | 2.21973391 |
82 | Bundle branch block (HP:0011710) | 2.20580754 |
83 | Spastic gait (HP:0002064) | 2.20385788 |
84 | Hepatic necrosis (HP:0002605) | 2.18755244 |
85 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18533333 |
86 | Dementia (HP:0000726) | 2.15692535 |
87 | Congenital primary aphakia (HP:0007707) | 2.15483085 |
88 | Abnormality of macrophages (HP:0004311) | 2.14109191 |
89 | X-linked dominant inheritance (HP:0001423) | 2.12536181 |
90 | Dysdiadochokinesis (HP:0002075) | 2.12181819 |
91 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.11967974 |
92 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.11967974 |
93 | Impaired social interactions (HP:0000735) | 2.11747238 |
94 | Abnormal social behavior (HP:0012433) | 2.11747238 |
95 | Depression (HP:0000716) | 2.11205387 |
96 | Respiratory failure (HP:0002878) | 2.10961868 |
97 | Lipid accumulation in hepatocytes (HP:0006561) | 2.09590004 |
98 | Akinesia (HP:0002304) | 2.09579508 |
99 | Disinhibition (HP:0000734) | 2.07914089 |
100 | Psychosis (HP:0000709) | 2.07635695 |
101 | Insidious onset (HP:0003587) | 2.07277081 |
102 | Termporal pattern (HP:0011008) | 2.07277081 |
103 | Purpura (HP:0000979) | 2.06581865 |
104 | Tetraparesis (HP:0002273) | 2.05780480 |
105 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05479071 |
106 | Increased cerebral lipofuscin (HP:0011813) | 2.05238074 |
107 | Generalized myoclonic seizures (HP:0002123) | 2.04426780 |
108 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.04084749 |
109 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.04084749 |
110 | Hemiparesis (HP:0001269) | 2.03571841 |
111 | Upper limb amyotrophy (HP:0009129) | 2.03090260 |
112 | Distal upper limb amyotrophy (HP:0007149) | 2.03090260 |
113 | Abnormal hair whorl (HP:0010721) | 2.02620765 |
114 | Hypsarrhythmia (HP:0002521) | 2.02251121 |
115 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.02180912 |
116 | Increased intramyocellular lipid droplets (HP:0012240) | 2.00585528 |
117 | Hand muscle atrophy (HP:0009130) | 2.00195680 |
118 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.99904503 |
119 | Distal lower limb muscle weakness (HP:0009053) | 1.97462676 |
120 | Retinal dysplasia (HP:0007973) | 1.97393997 |
121 | Hyperparathyroidism (HP:0000843) | 1.97004387 |
122 | Cerebral hemorrhage (HP:0001342) | 1.96797008 |
123 | Lactic acidosis (HP:0003128) | 1.95925552 |
124 | Exercise intolerance (HP:0003546) | 1.95557491 |
125 | Excessive salivation (HP:0003781) | 1.95531795 |
126 | Drooling (HP:0002307) | 1.95531795 |
127 | Ankle clonus (HP:0011448) | 1.95276603 |
128 | Abnormality of the corticospinal tract (HP:0002492) | 1.95169743 |
129 | Poor suck (HP:0002033) | 1.94654453 |
130 | Ventricular fibrillation (HP:0001663) | 1.92316179 |
131 | Peripheral hypomyelination (HP:0007182) | 1.91477264 |
132 | Failure to thrive in infancy (HP:0001531) | 1.90312811 |
133 | Dysautonomia (HP:0002459) | 1.89994887 |
134 | Abnormal gallbladder physiology (HP:0012438) | 1.88893254 |
135 | Cholecystitis (HP:0001082) | 1.88893254 |
136 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.86547951 |
137 | Hyperthyroidism (HP:0000836) | 1.86384055 |
138 | Resting tremor (HP:0002322) | 1.85957245 |
139 | Bradykinesia (HP:0002067) | 1.85220043 |
140 | Mutism (HP:0002300) | 1.85064712 |
141 | Blue irides (HP:0000635) | 1.84836857 |
142 | Esotropia (HP:0000565) | 1.84835238 |
143 | Systemic lupus erythematosus (HP:0002725) | 1.84191097 |
144 | Type II lissencephaly (HP:0007260) | 1.83919129 |
145 | Oligomenorrhea (HP:0000876) | 1.83903626 |
146 | Genital tract atresia (HP:0001827) | 1.83887112 |
147 | Vaginal atresia (HP:0000148) | 1.83606140 |
148 | Rapidly progressive (HP:0003678) | 1.81836179 |
149 | Hypoventilation (HP:0002791) | 1.80446863 |
150 | Emotional lability (HP:0000712) | 1.80138253 |
151 | Upper limb muscle weakness (HP:0003484) | 1.80119173 |
152 | Postural tremor (HP:0002174) | 1.77773260 |
153 | Asymmetric septal hypertrophy (HP:0001670) | 1.77047400 |
154 | Diminished movement (HP:0002374) | 1.72003417 |
155 | Lower limb muscle weakness (HP:0007340) | 1.71278895 |
156 | Choreoathetosis (HP:0001266) | 1.70344217 |
157 | Spastic tetraparesis (HP:0001285) | 1.66254712 |
158 | Tongue fasciculations (HP:0001308) | 1.65229277 |
159 | Abnormal atrioventricular conduction (HP:0005150) | 1.63976920 |
160 | Postural instability (HP:0002172) | 1.61841565 |
161 | Hyporeflexia of lower limbs (HP:0002600) | 1.61535497 |
162 | Esophageal neoplasm (HP:0100751) | 1.60653683 |
163 | Neoplasm of head and neck (HP:0012288) | 1.60653683 |
164 | CNS hypomyelination (HP:0003429) | 1.59608967 |
165 | Global brain atrophy (HP:0002283) | 1.59578293 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K12 | 3.81092556 |
2 | NTRK3 | 3.67426018 |
3 | EPHA4 | 3.52837844 |
4 | RIPK4 | 3.35953390 |
5 | CASK | 3.01989827 |
6 | MAP3K4 | 2.97790743 |
7 | MAP3K9 | 2.82073994 |
8 | MAP2K7 | 2.77999866 |
9 | ARAF | 2.68311038 |
10 | TESK1 | 2.48522495 |
11 | GRK5 | 2.40004159 |
12 | NME2 | 2.35604137 |
13 | PLK2 | 2.29245441 |
14 | MINK1 | 2.23501243 |
15 | DAPK2 | 2.15821708 |
16 | NTRK1 | 1.97724531 |
17 | PNCK | 1.95463865 |
18 | IRAK3 | 1.93601388 |
19 | MAP2K4 | 1.92561316 |
20 | LATS2 | 1.85581907 |
21 | MAP3K11 | 1.79253899 |
22 | OXSR1 | 1.79092319 |
23 | DAPK1 | 1.72529224 |
24 | NME1 | 1.70322026 |
25 | KSR2 | 1.69379266 |
26 | CDK19 | 1.65286341 |
27 | BMPR2 | 1.63489809 |
28 | MARK1 | 1.62467259 |
29 | TAOK2 | 1.56115309 |
30 | GRK7 | 1.54341227 |
31 | PAK6 | 1.26311607 |
32 | NTRK2 | 1.23257169 |
33 | CDK5 | 1.23062550 |
34 | FGR | 1.22608688 |
35 | CAMKK2 | 1.20869044 |
36 | MAP3K13 | 1.20834055 |
37 | CAMK2A | 1.19432314 |
38 | PTK2B | 1.18192695 |
39 | PRKCG | 1.14612416 |
40 | MAP3K2 | 1.13820239 |
41 | MAP3K3 | 1.12805564 |
42 | PAK4 | 1.11252869 |
43 | STK39 | 1.09495197 |
44 | BCR | 1.06847930 |
45 | CAMK2B | 1.06785732 |
46 | FES | 1.03508863 |
47 | EIF2AK1 | 1.02526491 |
48 | RIPK1 | 1.02108548 |
49 | SCYL2 | 1.01387407 |
50 | KSR1 | 0.99744179 |
51 | WNK4 | 0.96811041 |
52 | PRKD3 | 0.96642418 |
53 | PRKCE | 0.95846533 |
54 | TNIK | 0.94292573 |
55 | BRAF | 0.92263342 |
56 | PIM2 | 0.89623273 |
57 | ALK | 0.89554055 |
58 | MYLK | 0.83625649 |
59 | MAPK13 | 0.82437806 |
60 | CAMK2D | 0.80943505 |
61 | ILK | 0.80870476 |
62 | MAPK12 | 0.80200579 |
63 | WNK3 | 0.78566954 |
64 | PRPF4B | 0.75982019 |
65 | CDK14 | 0.75663534 |
66 | SGK223 | 0.75308018 |
67 | SGK494 | 0.75308018 |
68 | UHMK1 | 0.75301105 |
69 | PDK1 | 0.74980715 |
70 | STK16 | 0.74923142 |
71 | ADRBK1 | 0.74853035 |
72 | DDR2 | 0.74628497 |
73 | DAPK3 | 0.73325755 |
74 | AKT3 | 0.72612964 |
75 | ADRBK2 | 0.72612863 |
76 | CAMKK1 | 0.72091071 |
77 | PRKG2 | 0.71207055 |
78 | SIK3 | 0.70490543 |
79 | CDK18 | 0.69785701 |
80 | CAMK2G | 0.69449884 |
81 | MST4 | 0.68117551 |
82 | MUSK | 0.67125923 |
83 | CCNB1 | 0.67037567 |
84 | MAP2K1 | 0.66994811 |
85 | RAF1 | 0.66651627 |
86 | CSNK1G2 | 0.65806704 |
87 | PAK1 | 0.64484858 |
88 | CDK15 | 0.64277420 |
89 | GRK6 | 0.64250788 |
90 | MAPKAPK5 | 0.64074070 |
91 | LIMK1 | 0.62813507 |
92 | TBK1 | 0.62636103 |
93 | DYRK1A | 0.62377336 |
94 | MAP2K6 | 0.62005236 |
95 | MAP3K5 | 0.61292914 |
96 | MAPKAPK3 | 0.59760076 |
97 | PDK3 | 0.59261935 |
98 | PDK4 | 0.59261935 |
99 | MAP3K1 | 0.58890973 |
100 | PTK2 | 0.57168701 |
101 | PAK3 | 0.57001701 |
102 | FER | 0.56987850 |
103 | PRKCH | 0.55897849 |
104 | CDK11A | 0.55296683 |
105 | SIK2 | 0.55196482 |
106 | BMX | 0.54831786 |
107 | PDK2 | 0.54692176 |
108 | TESK2 | 0.54672176 |
109 | PDPK1 | 0.51301882 |
110 | PBK | 0.51202550 |
111 | PHKG1 | 0.50556268 |
112 | PHKG2 | 0.50556268 |
113 | BMPR1B | 0.50216809 |
114 | DMPK | 0.48832843 |
115 | PINK1 | 0.47655811 |
116 | SGK1 | 0.47356907 |
117 | ROCK2 | 0.45669995 |
118 | PRKACA | 0.44127509 |
119 | LMTK2 | 0.43697609 |
120 | TAOK1 | 0.43249143 |
121 | MAP2K3 | 0.42904816 |
122 | EPHB1 | 0.41470151 |
123 | JAK1 | 0.40977094 |
124 | CAMK1 | 0.40850938 |
125 | MOS | 0.40266205 |
126 | JAK2 | 0.39567611 |
127 | RET | 0.38749067 |
128 | ABL2 | 0.38416289 |
129 | INSRR | 0.37209995 |
130 | IRAK2 | 0.37092773 |
131 | CSNK1G3 | 0.36896768 |
132 | STK38 | 0.36281667 |
133 | PRKCZ | 0.35198283 |
134 | FYN | 0.34940064 |
135 | ERBB4 | 0.34509830 |
136 | PRKCA | 0.33743167 |
137 | ROCK1 | 0.32899429 |
138 | AKT2 | 0.31523265 |
139 | PRKCD | 0.30735757 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.71942593 |
2 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.70228781 |
3 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.50337177 |
4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.48326668 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.79532321 |
6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53594897 |
7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.53160188 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.39924485 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.29872318 |
10 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.26042416 |
11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.16841617 |
12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.12562311 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 2.09704125 |
14 | Circadian entrainment_Homo sapiens_hsa04713 | 2.09598655 |
15 | Olfactory transduction_Homo sapiens_hsa04740 | 2.08343325 |
16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.98224902 |
17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90328982 |
18 | Taste transduction_Homo sapiens_hsa04742 | 1.89427619 |
19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.86409302 |
20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.81772920 |
21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.80839794 |
22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.74193156 |
23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.70058931 |
24 | Salivary secretion_Homo sapiens_hsa04970 | 1.69397804 |
25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.68292897 |
26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.60882115 |
27 | Insulin secretion_Homo sapiens_hsa04911 | 1.59286535 |
28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56747860 |
29 | Renin secretion_Homo sapiens_hsa04924 | 1.52393858 |
30 | Long-term depression_Homo sapiens_hsa04730 | 1.50755891 |
31 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.48010449 |
32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45684043 |
33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45195437 |
34 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41735741 |
35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.40708382 |
36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35034748 |
37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29580332 |
38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.26317042 |
39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24746433 |
40 | Phototransduction_Homo sapiens_hsa04744 | 1.18890432 |
41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14083943 |
42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12901231 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11429035 |
44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08970127 |
45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04754791 |
46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04369837 |
47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03171407 |
48 | * Phagosome_Homo sapiens_hsa04145 | 1.03071243 |
49 | Endocytosis_Homo sapiens_hsa04144 | 0.99389611 |
50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95971190 |
51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95952835 |
52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94928563 |
53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91837319 |
54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86824738 |
55 | Protein export_Homo sapiens_hsa03060 | 0.85082281 |
56 | Gap junction_Homo sapiens_hsa04540 | 0.84956584 |
57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83854443 |
58 | Shigellosis_Homo sapiens_hsa05131 | 0.79287724 |
59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79135815 |
60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78179079 |
61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77751283 |
62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.75886928 |
63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75554737 |
64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74209108 |
65 | Proteasome_Homo sapiens_hsa03050 | 0.73874406 |
66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73766427 |
67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72307039 |
68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71568024 |
69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69751147 |
70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68707449 |
71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67426640 |
72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65119259 |
73 | Pertussis_Homo sapiens_hsa05133 | 0.63938396 |
74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63750573 |
75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63309501 |
76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62166308 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61250959 |
78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60868317 |
79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60040261 |
80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59780365 |
81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59056039 |
82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58026100 |
83 | Axon guidance_Homo sapiens_hsa04360 | 0.57861158 |
84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57838069 |
85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57764679 |
86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56790958 |
87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55534300 |
88 | Melanogenesis_Homo sapiens_hsa04916 | 0.55528320 |
89 | Legionellosis_Homo sapiens_hsa05134 | 0.54757891 |
90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54576291 |
91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53089833 |
92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52679088 |
93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52543296 |
94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48305707 |
95 | Lysosome_Homo sapiens_hsa04142 | 0.48292822 |
96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48196397 |
97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45659483 |
98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44210894 |
99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43699002 |
100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43673651 |
101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43616002 |
102 | Amoebiasis_Homo sapiens_hsa05146 | 0.43510521 |
103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43305493 |
104 | Glioma_Homo sapiens_hsa05214 | 0.42288468 |
105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42011774 |
106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41674568 |
107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41474509 |
108 | Prion diseases_Homo sapiens_hsa05020 | 0.41230441 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33841133 |
110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32713957 |
111 | Mineral absorption_Homo sapiens_hsa04978 | 0.32619906 |
112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30018451 |
113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29496837 |
114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29298439 |
115 | Alcoholism_Homo sapiens_hsa05034 | 0.29089890 |
116 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28254315 |
117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27520756 |
118 | Tuberculosis_Homo sapiens_hsa05152 | 0.27360276 |
119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27280522 |
120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27101688 |
121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26143615 |
122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25459775 |
123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25258111 |
124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24338483 |
125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22907671 |
126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20380158 |
127 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.20050838 |
128 | Salmonella infection_Homo sapiens_hsa05132 | 0.19348513 |
129 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.19196886 |
130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18840553 |
131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18073642 |